Automated sample prep market seen hitting $3.45 billion by 2030

The global automated sample preparation market is projected to grow from $2.14 billion in 2026 to $3.45 billion by 2030, driven by lab automation, infectious disease testing and AI-enabled workflows. North America held the largest share in 2025 as the market expands across clinical, pharmaceutical and research uses.

Why it matters: - Automated sample preparation is becoming a core part of lab operations as demand rises for faster, more accurate and more reproducible testing. - The market’s growth points to continued investment in laboratory automation, especially in diagnostics, pharmaceutical research and smart lab infrastructure. - Rising infectious disease testing needs are adding pressure for standardized sample handling and higher-throughput workflows.

What happened: - The Business Research Company said the automated sample preparation market reached $1.9 billion in 2025 and is expected to rise to $2.14 billion in 2026. - The market is forecast to reach $3.45 billion by 2030, reflecting a 12.7% compound annual growth rate during the forecast period. - North America held the largest regional share in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report is titled Automated Sample Preparation Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The company also offered a free sample of the report and a full report.

The details: - Automated sample preparation uses equipment and systems to manage and process samples for analysis or testing. - The process streamlines mixing, dilution and filtration. - The technology is designed to improve accuracy and operational efficiency. - Reduced manual labor lowers human error and helps deliver more consistent lab results. - Historical growth has been supported by laboratory automation, more clinical and research samples, a stronger focus on reproducibility, expanded pharmaceutical R&D and more advanced laboratory instruments. - Forecast growth is tied to broader adoption of fully automated labs, demand for precise diagnostics, expansion in personalized medicine research, investment in smart lab infrastructure and AI-driven analytics in sample preparation. - The report highlights growing use of robotic liquid handling systems, higher demand for high-throughput sample processing, wider adoption of automated workstations, efforts to reduce sample handling errors and more standardized lab workflows. - The report says the market’s growth is being helped by the rise in infectious diseases worldwide. - CDC data cited in the release showed U.S. tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023. - The CDC data also showed the U.S. tuberculosis incidence rate rose from 2.5 per 100,000 people in 2022 to 2.9 in 2023.

Between the lines: - The report frames automation as a response to both scale and quality pressures in modern labs. - The mix of diagnostics, pharma and personalized medicine demand suggests the market is moving beyond routine lab efficiency into more specialized clinical and research use cases. - The focus on AI, robotics and high-throughput systems signals a shift toward integrated lab platforms rather than isolated automation tools.

What's next: - The report expects more fully automated laboratories to come online over the forecast period. - More adoption of AI-supported sample prep and robotic systems is likely as labs try to speed processing and cut errors. - Regional growth outside North America may accelerate as the market expands into more geographies and lab segments. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel dashboards, market hotspots infographics and updated graphics and tables.